Dongni Yu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Mesenchymal Stem Cells

Placebo Controlled

Top Venues

Diabetes, obesity & metabolism

Aging medicine (Milton (N.S.W))

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Xin Guo, Fengsheng Tian, Li Liu, Mingwei Chen, Chengxia Jiang, Shuangqing Li, Cong Liu, Yawei Zhang, Jie Qin, Dongni Yu, Yicen Zong, Wei Dai
Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes, obesity & metabolism (2024)
Li-Xin Guo, Fengsheng Tian, Li Liu, Mingwei Chen, Chengxia Jiang, Shuangqing Li, Cong Liu, Yawei Zhang, Jie Qin, Dongni Yu, Yicen Zong, Wei Dai
Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes, obesity & metabolism 26 (7) (2024)
Li-Xin Guo, Fengsheng Tian, Li Liu, Mingwei Chen, Chengxia Jiang, Shuangqing Li, Cong Liu, Yawei Zhang, Jie Qin, Dongni Yu, Yicen Zong, Wei Dai
Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes, obesity & metabolism 26 (7) (2024)
Dongni Yu, Mingyue Cheng, Lixin Guo, Wenli Liu, Ye Liu, Kang Ning, Yigang Tong, Xuejiao Yan, Lei Qiu, Haimei Qi
Influence of oral nutritional agents rich in soluble dietary fiber on intestinal flora of elderly men with malnutrition. Aging medicine (Milton (N.S.W)) 4 (3) (2021)